Abbott Labs falls after jury awards plaintiff $495M in damages in baby formula case

Similac Baby Formula

LPETT

Update at 8:10 PM: Damage update, adds Abbott’s comment.

Abbott Laboratories (New York:ABT) decreased by 5% In after-hours trading after a St. Louis jury awarded a plaintiff $495 million in damages and penalties over allegations that the company’s infant formula caused

The post Abbott Labs falls after jury awards plaintiff $495M in damages in baby formula case first appeared on Investorempires.com.